AHCO

Adapthealth Corp. Health Care Services-Home Health Care Services Russell 3000
$5.81Close $787.0MMarket cap $5.22 – $13.3852-week range Nov 3, 2026Next report · before the open

Highlights

Cautions

  • Not in an uptrend 0 of 8 trend conditions
  • Lagging the market RS 3 · weaker than 97% of stocks over 12 months
  • Far from its high 57% below its 52-week high
  • Earnings shrinking EPS −1019% year on year
  • Results soon Nov 3, 2026, in 2 days
  • Financial distress Altman Z″ in the distress zone

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 4, 2026
Off 12-month high 57%
1wk down 3.5% price change
1mo up 3.0% price change
12-month return down 35% market up 11% · its own down 47%
F-score 3 / 9 Weak
Altman Z″ 0.26 Elevated risk
P/E — price / earnings
PEG — P/E / EPS growth
P/B 0.5× price / book
Earnings yield up 3.8% EBIT / enterprise value
Cheaper than 84% of the market · markedly cheap
Revenue growth 0% year on year
EPS growth down 1019% latest quarter
Sales growth up 13% latest quarter · +7 pts
ROE down 5% return on equity
Free cash margin up 7% $219.4M FCF
D/E 1.13 long-term debt / equity
Net debt / EBITDA 3.4×
Interest cover 0.9×EBIT / interest
Piotroski tests
  • not yet profitable on its assets
  • profitability slipped from last year
  • short-term liquidity weakened
  • issued more shares
  • gross margin narrowed
  • assets working less efficiently
  • generating cash from operations
  • profits backed by cash
  • reduced long-term debt

Repair signals

  • Long-term debt down 13% ($2.0B → $1.7B)

Trade setup

ATR% 4.5% $0.26 a day · 2×ATR $5.28
RS 3 / 99 vs the universe
Trend 0 / 8 trend template
Relative volume 0.9× vs 50-day average
Up/down volume 1.01 50 sessions
Implied move — no option chain · report Nov 3, 2026
Trend template · 0 of 8

Screen verdict

Did not qualify for any screen.

Warning signs

4 flagged
  • Bankruptcy model reads distressed The Altman score sits inside the range historically associated with financial distress. It is used here only to exclude, never to rank, and it is a statistical band rather than a prediction about this company.
  • Interest is covered, but thinly Earnings before interest cover the interest bill 0.9 times, leaving little room if profits fall.
  • Gross margin narrowing Gross margin fell from 20.9% to 18.8%. The company is keeping less of each dollar of sales than it did a year ago.
  • Revenue shrinking Revenue fell 0.5% over the year, from $3.3B to $3.2B.
Last reported Aug 4, 2026
Last shock Aug 4, 2026-38% in one session10.9× volumeon results-13% since

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $3.2B -0.5% on FY2024
$0 $5B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $1.1B FY2021 · $2.5B FY2022 · $3.0B FY2023 · $3.2B FY2024 · $3.3B FY2025 · $3.2B
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology -$70.8M down to a loss
-$1B $0 $200M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · -$161.6M FY2021 · $156.2M FY2022 · $69.3M FY2023 · -$678.9M FY2024 · $90.4M FY2025 · -$70.8M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $219.4M -7% on FY2024
$0 $250M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $155.9M FY2021 · $72.4M FY2022 · -$17.6M FY2023 · $143.2M FY2024 · $235.8M FY2025 · $219.4M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 19%
  • Net -2%
  • Free cash 7%
-25% 0% 25% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 15% · Net -15% · Free cash 15% FY2021 · Gross 18% · Net 6% · Free cash 3% FY2022 · Gross 20% · Net 2% · Free cash -1% FY2023 · Gross 20% · Net -21% · Free cash 4% FY2024 · Gross 21% · Net 3% · Free cash 7% FY2025 · Gross 19% · Net -2% · Free cash 7%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $1.6B net debt
  • Cash
  • Long-term debt
$0 $2.5B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $100.0M · Long-term debt $776.6M FY2021 · Cash $149.6M · Long-term debt $2.2B FY2022 · Cash $46.3M · Long-term debt $2.2B FY2023 · Cash $77.1M · Long-term debt $2.1B FY2024 · Cash $109.7M · Long-term debt $2.0B FY2025 · Cash $106.1M · Long-term debt $1.7B
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 135.45m
135.45m 132.63m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 FY2021 · 133.84m FY2022 · 134.44m FY2023 · 132.63m FY2024 · 134.60m FY2025 · 135.45m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $1.1B $2.5B $3.0B $3.2B $3.3B $3.2B
Gross margin 15% 18% 20% 20% 21% 19%
Operating income $71.3M $225.6M $190.4M -$598.4M $263.7M $90.9M
Net income -$161.6M $156.2M $69.3M -$678.9M $90.4M -$70.8M
Net margin -15% 6% 2% -21% 3% -2%
Earnings per share -$3.08 $1.17 $0.50 -$5.05 $0.67 -$0.52
Free cash flow $155.9M $72.4M -$17.6M $143.2M $235.8M $219.4M
Free cash margin 15% 3% -1% 4% 7% 7%
Cash $100.0M $149.6M $46.3M $77.1M $109.7M $106.1M
Long-term debt $776.6M $2.2B $2.2B $2.1B $2.0B $1.7B
Shareholders' equity $354.9M $2.1B $2.2B $1.5B $1.6B $1.5B
Shares outstanding — 133.84m 134.44m 132.63m 134.60m 135.45m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 4, 2026 Quarterly ↗ Jun 30, 2026 35d
May 5, 2026 Quarterly ↗ Mar 31, 2026 35d
Feb 24, 2026 Annual ↗ Dec 31, 2025 55d
Nov 4, 2025 Quarterly ↗ Sep 30, 2025 35d
Aug 5, 2025 Quarterly ↗ Jun 30, 2025 36d
May 6, 2025 Quarterly ↗ Mar 31, 2025 36d
Feb 25, 2025 Annual ↗ Dec 31, 2024 56d
Nov 5, 2024 Quarterly ↗ Sep 30, 2024 36d
Aug 6, 2024 Quarterly ↗ Jun 30, 2024 37d
May 7, 2024 Quarterly ↗ Mar 31, 2024 37d
Feb 27, 2024 Annual ↗ Dec 31, 2023 58d
Nov 7, 2023 Quarterly ↗ Sep 30, 2023 38d

Current reports